(Q40693029)

English

Chronic rapamycin treatment causes glucose intolerance and hyperlipidemia by upregulating hepatic gluconeogenesis and impairing lipid deposition in adipose tissue

scientific article published on 18 March 2010

Statements

Chronic rapamycin treatment causes glucose intolerance and hyperlipidemia by upregulating hepatic gluconeogenesis and impairing lipid deposition in adipose tissue (English)
1 reference
Vanessa P Houde
1 reference
Sophie Brûlé
1 reference
Pierre-Gilles Blanchard
1 reference
Kerstin Bellmann
1 reference
Yves Deshaies
1 reference
André Marette
1 reference
18 March 2010
1 reference
59
1 reference
6
1 reference
1338-1348
1 reference

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit